Publication: Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor-A Multicenter Cohort Study
| dc.authorscopusid | 57203951445 | |
| dc.authorscopusid | 55541727500 | |
| dc.authorscopusid | 8661414300 | |
| dc.authorscopusid | 7004442894 | |
| dc.authorscopusid | 56235570700 | |
| dc.authorscopusid | 57216677377 | |
| dc.authorscopusid | 6602557128 | |
| dc.contributor.author | Okay, M. | |
| dc.contributor.author | Aslan, T. | |
| dc.contributor.author | Özdemir, E. | |
| dc.contributor.author | Üner, A. | |
| dc.contributor.author | Saǧlam, A. | |
| dc.contributor.author | Güngör, E. | |
| dc.contributor.author | Uysal, A. | |
| dc.date.accessioned | 2020-06-21T12:18:50Z | |
| dc.date.available | 2020-06-21T12:18:50Z | |
| dc.date.issued | 2020 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Okay] Mufide, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey; [Aslan] Tuncay, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey; [Özdemir] Evren, Department of Medical Oncology, Ankara Numune Hospital, Ankara, Turkey; [Üner] Ayşegül Hasegeli, Hacettepe Üniversitesi, Ankara, Turkey; [Saǧlam] Arzu Emine, Hacettepe Üniversitesi, Ankara, Turkey; [Güngör] Elif, Department of Internal Medicine, Trakya Üniversitesi, Edirne, Edirne, Turkey; [Uysal] Ayse Oruç, Division of Hematology, University of Health Sciences, Istanbul, Turkey; [Aslan] Nevin Alayvaz, Department of Hematology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yildizhan] Esra Taş, Department of Hematology, Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Agit] Abdullah, Division of Hematology, Ankara Numune Education and Research Hospital, Ankara, Turkey; [Sinan Dal] Mehmet, Department of Hematology and BMT Unit, University of Health Sciences, Istanbul, Turkey; [Korkmaz] Serdal, Division of Hematology, Kayseri Training and Research Hospital, Kayseri, Kayseri, Turkey; [Namdaroǧlu] Sinem, University of Health Sciences, Istanbul, Turkey; [Şivgin] Serdar, Acibadem Kayseri Hospital, Kayseri, Kayseri, Turkey; [Çağlıyan] Gülsüm Akgün, Division of Hematology, T. C. Sağlık Bakanlığı, Denizli Devlet Hastanesi, Denizli, Turkey; [Demircioglu] Sinan, Department of Hematology, Van Yüzüncü Yıl Üniversitesi, Van, Turkey; [Barişta] Ïbrahim, Department of Medical Oncology, Hacettepe Üniversitesi, Ankara, Turkey; [Özhamam] Esra Ucaryilmaz, Division of Pathology, Ankara Numune Education and Research Hospital, Ankara, Turkey; [Vural] Filiz, Department of Internal Medicine, Ege Üniversitesi, Izmir, Turkey; [Eser] Bülent, Department of Hematology, Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Özet] Gülsüm Gulistan, Division of Hematology, Ankara Numune Education and Research Hospital, Ankara, Turkey; [Yıldırım] Rahşan, Department of Hematology, Atatürk Üniversitesi, Erzurum, Erzurum, Turkey; [Doǧu] Mehmet Hilmi, Clinic of Hematology, T. C. Sağlık Bakanlığı, Taksim Eğitim ve Araştirma Hastanesi, Istanbul, Turkey; [Berber] Ilhami, Division of Hematology, Malatya Training and Research Hospital, Malatya, Malatya, Turkey; [Erkurt] Mehmet Ali, Department of Internal Medicine, Inönü Üniversitesi, Malatya, Turkey; [Malkan] Umit Yavuz, Clinic of Hematology, University of Health Sciences, Istanbul, Turkey; [Altuntaş] Fevzi, Department of Hematology and BMT Unit, University of Health Sciences, Istanbul, Turkey, Department of Internal Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey; [Buyukasik] Yahya, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey | en_US |
| dc.description.abstract | Objective: Chronic antigenic stimulation is frequently blamed in the pathogenesis of extranodal marginal zone lymphomas including splenic marginal zone lymphoma (SMZL). Chronic hepatitis C is frequently observed in SMZL patients in some geographical regions. However, these reports are largely from North America and Europe, and data from other countries are insufficient. In this multicenter study we aimed to identify the clinical characteristics of SMZL patients in Turkey, including viral hepatitis status and treatment details. Materials and Methods: Data were gathered from participating centers from different regions of Turkey using IBM SPSS Statistics 23 for Windows. Hepatitis B virus surface antigen (HBsAg), anti-HBs antibody, anti-HB core antigen antibody (anti-HBcAg), HB viral load, anti-hepatitis C virus (HCV) antibody, HCV viral load results were analyzed. Results: One hundred and four patients were reported. Hepatitis C virus positivity was observed in only one patient. However, hepatitis B virus surface antigen (HBsAg) positivity was observed in 11.2% and HBsAg and/or anti-HB core antigen antibody (anti-HBcAg) positivities were seen in 34.2% of the patients. The median age was 60 years (range=35-87). Median follow-up duration was 21.2 months (range=00.2-212; 23.2 months for surviving patients). Median overall survival was not reached. Estimated 3-year and 10-year survival rates were 84.8% and 68.9%, respectively. Older age, no splenectomy during follow-up, platelet count of <90x103/µL, lower albumin, higher lactate dehydrogenase, higher β<inf>2</inf>-microglobulin, and HBsAg positivity were associated with increased risk of death. Only albumin remained significant in multivariable analysis. Conclusion: These results indicate that hepatitis B virus may be a possible risk factor for SMZL in our population. It may also be an indirect prognostic factor. © 2020 by Turkish Society of Hematology. | en_US |
| dc.identifier.doi | 10.4274/tjh.galenos.2019.2019.0177 | |
| dc.identifier.endpage | 90 | en_US |
| dc.identifier.issn | 1300-7777 | |
| dc.identifier.issn | 1308-5263 | |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.pmid | 31630512 | |
| dc.identifier.scopus | 2-s2.0-85084273046 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 84 | en_US |
| dc.identifier.trdizinid | 365927 | |
| dc.identifier.uri | https://doi.org/10.4274/tjh.galenos.2019.2019.0177 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/en/yayin/detay/365927/splenic-marginal-zone-lymphoma-in-turkey-association-with-hepatitis-b-instead-of-hepatitis-c-virus-as-an-etiologic-and-possible-prognostic-factor-a-multicenter-cohort-study | |
| dc.identifier.volume | 37 | en_US |
| dc.identifier.wos | WOS:000531086600002 | |
| dc.identifier.wosquality | Q3 | |
| dc.language.iso | en | en_US |
| dc.publisher | Turkish Society of Hematology | en_US |
| dc.relation.ispartof | Turkish Journal of Hematology | en_US |
| dc.relation.journal | Turkish Journal of Hematology | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Hepatitis B Virus | en_US |
| dc.subject | Hepatitis C Virus | en_US |
| dc.subject | Low-Grade Lymphoma | en_US |
| dc.subject | Risk Factors | en_US |
| dc.title | Splenic Marginal Zone Lymphoma in Turkey: Association With Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor-A Multicenter Cohort Study | en_US |
| dc.title.alternative | Türkiye’de Splenik Marjinal Zon Lenfoma: Hepatit C Virüs Yerine Hepatit B Virüsünün Etiyolojik ve Olası Prognostik Faktör Oluşu-Çok Merkezli Kohort Çalışması | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
